DJIA 17,817.90 7.84 0.04%
NASDAQ 4,754.89 41.92 0.89%
S&P 500 2,069.41 5.91 0.29%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

37.35 0.50 (1.36%)

REAL-TIME: Last trade at

Extended Hours: $37.35 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

SGEN $37.35 1.36%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $36.86
Previous Close $36.85
Daily Range $36.74 - $37.65
52-Week Range $30.80 - $55.99
Market Cap $4.6B
P/E Ratio -70.87
Dividend (Yield) $0.00 (0.0%)
Volume 892,142
Average Daily Volume 1,303,999
Current FY EPS -$0.68

Sector

Healthcare

Industry

Drugs

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seattlegenetics.com/

News & Commentary

3 Biotech Stocks to Watch in November

Biotech can be a tough sector for many investors. Here, our analysts share their three favorite picks as we go into November.

Seattle Genetics Inc. (SGEN): New Analyst Report from Zacks Equity Research - Zacks Equity Research

Seattle Genetics Inc. (SGEN): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

Why the Earnings Streak Will Continue for Seattle Genetics (SGEN) - Tale of the Tape

Friday's ETF Movers: GDXJ, BBH

5 Stocks With Big Insider Buying

Seattle Genetics (SGEN) Shows Signs Of Being Water-Logged And Getting Wetter

5 Health Care Stocks Hurting From The Affordable Care Act

Seattle Genetics Gains on Narrower-than-Expected Q3 Loss - Analyst Blog

Seattle Genetics' (SGEN) CEO Clay Siegall on Q3 2014 Results - Earnings Call Transcript

Analysts' Actions: Aegerion, Atmel, Avon, Seattle Genetics, More

See More SGEN News...

SGEN's Top Competitors

SGEN $37.35 (1.36%)
Current stock: SGEN
AMGN $164.18 (0.84%)
Current stock: AMGN
GILD $100.60 (0.02%)
Current stock: GILD
BIIB $306.74 (1.05%)
Current stock: BIIB